Bimzelx

bimekizumab

Approval

ApplicationBLA 761151
Approval dateOct 17, 2023
Approval year2023
SponsorUcb INC

FDA-approved use

To treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Bimzelx: